Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018
Author:
Funder
Arnold Ventures
Publisher
Elsevier BV
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference18 articles.
1. Treatment utilization among persons with opioid use disorder in the United States;Wu;Drug Alcohol Depend,2016
2. Medications for Opioid Use Disorder Save Lives,2019
3. Association between Medicare and FDA policies and prior authorization requirements for buprenorphine products in Medicare Part D plans;Mark;JAMA,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Retrospective study investigating naloxone prescribing and cost in US Medicaid and Medicare patients;BMJ Open;2024-05
2. Medicare Coverage of Buprenorphine-Naloxone Film Surrounding Generic Entry;The American Journal of Managed Care;2023-08-23
3. National Increase but Pronounced Regional Disparities in Naloxone Prescribing to United States Medicaid and Medicare Patients;2023-05-24
4. The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment;Applied Health Economics and Health Policy;2023-01-18
5. Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada;International Journal of Drug Policy;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3